ATRA (Atara Biotherapeutics) Dividends per Share: $0.00 (TTM As of Mar. 2026)

What is Atara Biotherapeutics Dividends per Share?

Atara Biotherapeutics ATRA -6.61% 31 Dividends per Share is $0.00 as of Mar. 2026. GuruFocus rates ATRA with a GF Score™ of 31/100 and a GF Value™ of $1.55 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Atara Biotherapeutics's dividends per share for the three months ended in Mar. 2026 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Atara Biotherapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Atara Biotherapeutics (NAS:ATRA) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Atara Biotherapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	-0.29
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atara Biotherapeutics Dividends per Share Related Terms

Atara Biotherapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Atara Biotherapeutics's Dividends per Share can be seen below:

Atara Biotherapeutics Dividends per Share Chart

Atara Biotherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

Atara Biotherapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ATRA vs ANIX, BMEA, PMN: Dividends per Share Comparison

For the Biotechnology subindustry, Atara Biotherapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atara Biotherapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's Dividend Yield % falls into.

Save Embed

31GF Score

Atara Biotherapeutics Inc ATRA

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Atara Biotherapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of $0.00 mean?

Atara Biotherapeutics (ATRA) has a Dividends per Share of $0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Atara Biotherapeutics and its competitors.

Is Atara Biotherapeutics' Dividends per Share too high?

Atara Biotherapeutics' current Dividends per Share is $0.00. Overall, Atara Biotherapeutics has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Atara Biotherapeutics' Dividends per Share compare to ANIX and BMEA?

Atara Biotherapeutics' Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Atara Biotherapeutics and its competitors. Atara Biotherapeutics's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Atara Biotherapeutics stock overvalued right now?

Based on GuruFocus' analysis, Atara Biotherapeutics (ATRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.55, compared to a current price of $10.89 — trading 602.6% above its estimated fair value. The current Dividends per Share is $0.00. Atara Biotherapeutics' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Atara Biotherapeutics (ATRA), the current Dividends per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atara Biotherapeutics (ATRA) Overvalued in 2026?

Based on GuruFocus' analysis, Atara Biotherapeutics stock appears to be overvalued. The current stock price of $10.89 is trading 602.6% above its estimated GF Value™ of $1.55. GuruFocus considers Atara Biotherapeutics to be Significantly Overvalued.

Key valuation signals for ATRA:

Dividends per Share: $0.00
GF Value™: $1.55 vs. price of $10.89 (602.6% above fair value)
GF Score™: 31/100 with 7 warning signs

No single metric tells the full story. See the ATRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atara Biotherapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies ANIX BMEA PMN CSBR SEER RLYB FBIO INO BDTX NRXS VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 0HIY:UK AT20:Germany

Address 1280 Rancho Conejo Boulevard, Suite 200, Thousand Oaks, CA, USA, 91320

Website https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

31GF Score

Get the complete analysis for ATRA

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.89

Price

$1.55

GF Value

View ATRA Analysis

See Dividends per Share data for all stocks →